35
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Role of mTOR in podocyte function and diabetic nephropathy in humans and mice.

      The Journal of clinical investigation
      Adaptor Proteins, Signal Transducing, Adult, Animals, Carrier Proteins, genetics, physiology, Diabetes Mellitus, Experimental, complications, physiopathology, Diabetic Nephropathies, pathology, Disease Progression, Gene Dosage, Genetic Predisposition to Disease, Humans, Kidney Glomerulus, Mice, Mice, Inbred C57BL, Mice, Inbred ICR, Mice, Knockout, Mice, Transgenic, Multiprotein Complexes, Nephrosis, Lipoid, Podocytes, drug effects, Proteins, Proteinuria, etiology, prevention & control, Sirolimus, therapeutic use, TOR Serine-Threonine Kinases, antagonists & inhibitors, Trans-Activators, deficiency, Transcription Factors

      Read this article at

      ScienceOpenPublisherPMC
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Chronic glomerular diseases, associated with renal failure and cardiovascular morbidity, represent a major health issue. However, they remain poorly understood. Here we have reported that tightly controlled mTOR activity was crucial to maintaining glomerular podocyte function, while dysregulation of mTOR facilitated glomerular diseases. Genetic deletion of mTOR complex 1 (mTORC1) in mouse podocytes induced proteinuria and progressive glomerulosclerosis. Furthermore, simultaneous deletion of both mTORC1 and mTORC2 from mouse podocytes aggravated the glomerular lesions, revealing the importance of both mTOR complexes for podocyte homeostasis. In contrast, increased mTOR activity accompanied human diabetic nephropathy, characterized by early glomerular hypertrophy and hyperfiltration. Curtailing mTORC1 signaling in mice by genetically reducing mTORC1 copy number in podocytes prevented glomerulosclerosis and significantly ameliorated the progression of glomerular disease in diabetic nephropathy. These results demonstrate the requirement for tightly balanced mTOR activity in podocyte homeostasis and suggest that mTOR inhibition can protect podocytes and prevent progressive diabetic nephropathy.

          Related collections

          Author and article information

          Comments

          Comment on this article